Please assess the completion status of the following clinical trial:

Trial Title: Safety and Effectiveness Assessment of the MakAir Artificial Ventilator

Study Design Characteristics:
- Allocation: None
- Intervention Model: SEQUENTIAL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~Sequence 1 :~* Patient for whom a certificate has been signed by a support person / family member / close relative independent of the sponsor.~* Adult~* Non-hypoxemic patient (PaO2 / FiO2\> 300)~* Patient requiring invasive mechanical ventilation\> 24 hours~* Stabilized patient, i.e. not needing an increase in oxygenation for at least 6 hours~Sequence 2 :~* Patient for whom a certificate of consent has been signed by a support person / family member / close relative independent of the sponsor.~* Adult~* Patient with mild to moderate Acute respiratory distress syndrome (300\> Pa02 / FiO2\> 100)~* Patient requiring invasive mechanical ventilation\> 3 days~* Stabilized patient, i.e. having not required an increase in oxygenation for at least 6 hours~Sequence3 :~* Patient for whom a certificate of consent has been signed by a support person / family member / close relative independent of the sponsor or waiver due to life-threatening emergency.~* Adult~* Patient with mild to moderate Acute respiratory distress syndrome (PaO2 / FiO2\> 100) or without Acute respiratory distress syndrome~* Patient requiring invasive mechanical ventilation for any duration~* Situation of shortage among centers investigating technical devices for invasive ventilation to treat all patients~Exclusion Criteria:~Sequence 1 and sequence 2:~* Patient positive or showing signs of Covid-19 infection~* Tracheotomized patient~* History of pulmonary emphysema or severe to moderate chronic obstructive pulmonary disease~* Patient in recovery and withdrawal phase of ventilatory assistance~* Pneumothorax or pneumomediastinum~* Hemodynamic instability~* Intracranial hypertension~* Pregnant woman (A urine or blood pregnancy test must be performed for women of childbearing age)~* Major protected (guardianship, curatorship and under the protection of justice)~* Lack of affiliation to the French social security system~* Participation in another interventional clinical trial~Sequence3 :~* Tracheotomized patient~* History of pulmonary emphysema or severe to moderate moderate chronic obstructive pulmonary disease~* Patient in recovery and withdrawal phase of ventilatory assistance~* Pneumothorax or pneumomediastinum~* Hemodynamic instability~* Intracranial hypertension~* Pregnant woman (A urine or blood pregnancy test must be performed for women of childbearing age)~* Major protected (guardianship, curatorship and under the protection of justice)~* Lack of affiliation to the French social security system~* Participation in another interventional clinical trial on mechanical ventilation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- MakAir (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).